Damon Runyon Researchers

Meet Our Scientists
Benjamin G. H. Guthrie, PhD

Dr. Guthrie seeks to understand how the microbiome—the collection of bacteria, fungi, viruses, and other organisms that inhabit the body—affects patients’ response to chemotherapeutics. His research focuses on fluoropyrimidines, small molecules that are used to treat colorectal, head and neck, and breast cancers, but are not well tolerated by all patients. While it is known why some patients in that subset display adverse effects, the reason for poor tolerance in others is unclear. Dr. Guthrie will use molecular, ecological, and organismal approaches to understand how our microbiome might inadvertently degrade or prematurely activate fluoropyrimidines.

Project title: "Fluoropyrimidine bioactivation and metabolism by the gut microbiome"
Institution: University of California, San Francisco
Named Award: Connie and Bob Lurie Fellow
Award Program: Fellow
Sponsor(s) / Mentor(s): Peter J. Turnbaugh, PhD
Cancer Type: All Cancers
Research Area: Biochemistry